Table 3.
Cancer site | Total population | Low educated c | Mid educated d | High educated e | MRD f,g (95% CI h) | |
---|---|---|---|---|---|---|
Total cancer mortality | ASMR a | 687.0 (682.0–692.1) | 729.8 (722.8–736.8) | 612.6 (600.5–624.6) | 491.4 (480.1–502.7) | 238.4 (234.1–242.7) |
MRR b | 1.55 (1.52–1.59) | 1.29 (1.25–1.33) | 1.00 | |||
Head and neck | ASMR | 30.7 (29.6–31.7) | 33.4 (31.8–34.9) | 26.4 (24.0–28.8) | 18.7 (16.6–20.7) | 14.7 (14.2–15.2) |
MRR | 1.95 (1.74–2.19) | 1.50 (1.31–1.72) | 1.00 | |||
Oesophagus | ASMR | 24.6 (23.6–25.5) | 24.9 (23.6–26.2) | 25.1 (22.7–27.5) | 21.4 (19.1–23.7) | 3.5 (2.5–4.5) |
MRR | 1.26 (1.12–1.42) | 1.24 (1.08–1.43) | 1.00 | |||
Stomach | ASMR | 22.0 (21.1–22.9) | 23.8 (22.5–25.0) | 17.2 (15.1–19.2) | 16.1 (14.0–18.1) | 7.7 (6.9–8.5) |
MRR | 1.50 (1.31–1.72) | 1.09 (0.92–1.29) | 1.00 | |||
Colorectal | ASMR | 65.9 (64.3–67.4) | 66.2 (64.1–68.3) | 63.2 (59.3–67.1) | 52.4 (50.4–58.0) | 13.8 (10.3–13.7) |
MRR | 1.25 (1.16–1.34) | 1.19 (1.09–1.30) | 1.00 | |||
Liver | ASMR | 19.5 (18.6–20.3) | 18.8 (17.7–20.0) | 20.7 (18.5–22.9) | 18.9 (16.7–21.2) | −0.1 (−1.2–1.0) |
MRR | 1.10 (0.96–1.25) | 1.20 (1.03–1.41) | 1.00 | |||
Pancreas | ASMR | 33.2 (32.0–34.3) | 33.8 (32.3–35.3) | 31.3 (28.5–34.0) | 33.5 (30.5–36.5) | 0.3 (−1.2–1.8) |
MRR | 1.07 (0.97–1.18) | 0.98 (0.87–1.11) | 1.00 | |||
Lung and trachea | ASMR | 252.9 (249.9–256.0) | 286.1 (281.7–290.5) | 196.7 (189.9–203.6) | 134.4 (128.5–140.3) | 151.7 (150.2–153.2) |
MRR | 2.23 (2.13–2.33) | 1.52 (1.44–1.60) | 1.00 | |||
Melanoma | ASMR | 6.0 (5.5–6.5) | 5.8 (5.2–6.4) | 7.0 (5.8–8.3) | 6.4 (5.2–7.7) | −0.6 (−1.3–0.0) |
MRR | 0.89 (0.72–1.11) | 1.05 (0.81–1.35) | 1.00 | |||
Prostate | ASMR | 48.4 (47.0–49.7) | 47.7 (45.9–49.4) | 46.7 (43.2–50.2) | 43.7 (40.2–47.3) | 4.0 (2.1–5.7) |
MRR | 1.11 (1.02–1.21) | 1.06 (0.95–1.18) | 1.00 | |||
Kidney | ASMR | 18.9 (18.0–19.7) | 19.1 (18.0–20.2) | 20.1 (17.8–22.3) | 16.8 (14.7–18.9) | 2.3 (1.3–3.3) |
MRR | 1.15 (1.00–1.31) | 1.17 (0.99–1.37) | 1.00 | |||
Bladder | ASMR | 24.8 (23.8–25.8) | 25.3 (24.0–26.6) | 23.3 (20.8–25.7) | 17.8 (15.6–20.0) | 7.5 (6.6–8.4) |
MRR | 1.49 (1.30–1.70) | 1.34 (1.14–1.57) | 1.00 | |||
Eye, brain, central nervous system | ASMR | 14.9 (14.2–15.7) | 14.9 (13.9–15.9) | 14.8 (13.0–16.7) | 14.1 (12.3–15.9) | 0.8 (0.0–1.6) |
MRR | 1.06 (0.92–1.22) | 1.04 (0.88–1.24) | 1.00 | |||
Non-Hodgkin Lymphoma | ASMR | 14.4 (13.7–15.1) | 13.9 (13.0–14.9) | 15.9 (13.9–17.9) | 13.2 (11.3–15.1) | 0.7 (−0.2–1.7) |
MRR | 1.09 (0.93–1.27) | 1.23 (1.02–1.47) | 1.00 | |||
Multiple myeloma | ASMR | 9.8 (9.2–10.4) | 9.9 (9.1–10.7) | 10.8 (9.2–12.5) | 8.6 (7.1–10.1) | 1.3 (0.6–2.0) |
MRR | 1.12 (0.93–1.35) | 1.20 (0.96–1.51) | 1.00 | |||
Leukaemia | ASMR | 18.9 (18.1–19.8) | 18.8 (17.7–19.9) | 19.1 (16.9–21.3) | 17.2 (15.0–19.4) | 1.6 (0.5–2.7) |
MRR | 1.14 (0.99–1.31) | 1.12 (0.95–1.33) | 1.00 |
aAge-standardized mortality rate using the Belgian population at the moment of the 2001 census as reference; expressed per 100,000 men
bMortality Rate Ratio
cLow-educated persons have completed lower secondary education or less
dMid-educated persons have completed upper secondary education
eHigh-education persons have completed tertiary education
fMortality rate difference
gThe difference between the ASMR of the lowest educated and the ASMR of the highest educated
h95% Confidence Intervals